col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


41 Ergebisse       Seite 1

 [1] 
SAGE Publications: Annals of Pharmacotherapy
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Jan―30 Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19 Hannah B. Knox, Lisa A. Dykes, Lancer A. Scott, Bradley C. Presley, Lara C. Lambert
2 [GO] 2023―Nov―28 Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials Marina Sánchez-Rico, Katayoun Rezaei, Eric J. Lenze, Frédéric Limosin, Nicolas Hoertel
3 [GO] 2023―Jul―31 Dosing and Administration Strategies of Tocilizumab in Patients With COVID-19: A Retrospective Cohort Analysis Taylor D. Steuber, Thomas Rosandich, Tiffany Cadwallader, Lauren Steil, Madeline Belk, Usha Yendrapalli, et al. (+2)
4 [GO] 2023―Mai―05 Adverse Events of SARS-CoV-2 Therapy: A Pharmacovigilance Study of the FAERS Database Viraaj Pannu, Ndausung Udongwo, Steven Imburgio, Anmol Johal, Anton Mararenko, Helen Pozdniakova, et al. (+7)
5 [GO] 2023―Apr―06 Comparison of COVID-19 Vaccination and Infection Rates in Adult Patients With Autoimmune Inflammatory Disease on b/tsDMARD Therapy Viktoriya Avlasevich, Katharine McCarthy
6 [GO] 2023―Apr―01 Efficacy and Safety of Fluvoxamine as Outpatient Treatment for Patients With Covid-19: A Systematic Review and Meta-analysis of Clinical Trials Akhil Deepak Vatvani, Andree Kurniawan, Timotius Ivan Hariyanto
7 [GO] 2023―Apr―01 Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19 Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
8 [GO] 2023―Feb―27 A Review of the Data Supporting Use of COVID-19 Vaccinations in the Pediatric Population Jeremy S. Stultz, Lea S. Eiland
9 [GO] 2023―Jan―14 Comparison of Sedation and Analgesia Requirements in Patients With SARS-CoV-2 Versus Non-SARS-CoV-2 Acute Respiratory Distress Syndrome on Veno-Venous ECMO Mariah I. Sigala, Diane Dreucean, Jesse E. Harris, Kevin R. Donahue, Fariedeh Bostan, Prakruthi Voore, et al. (+2)
10 [GO] 2022―Dez―28 Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19 Temeka Dawn Lewis-Wolfson, Kayla Rena Joyner
11 [GO] 2022―Dez―28 Comment: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19 Rujittika, PhD Mungmunpuntipantip, Viroj, MD Wiwanitkit
12 [GO] 2022―Nov―14 Proportion of Patients on Warfarin Therapy Who Are Eligible for Conversion to a Direct Oral Anticoagulant in the Setting of COVID-19 Rachel Hess, Elizabeth Renner, Erin Mouland, Denise Sutter-Long, Nghi Ha
13 [GO] 2022―Okt―29 Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19 Nancy Kierstin Reid, Kayla Rena Joyner, Temeka Dawn Lewis-Wolfson
14 [GO] 2022―Okt―29 Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis Kegang Zhan, Liuqi Weng, Li Qi, Luhan Wang, Hao Lin, Xiaoyu Fang, et al. (+2)
15 [GO] 2022―Okt―08 Fatal COVID-19 Pneumonia in a Rheumatoid Arthritis Patient Receiving Long-Term Rituximab Therapy Chrong-Reen Wang, Wei-Chieh Lin
16 [GO] 2022―Aug―09 Effectiveness and Safety of Enoxaparin Versus Unfractionated Heparin as Thromboprophylaxis in Hospitalized COVID-19 Patients: Real-World Evidence Lina H. AlLehaibi, Mukhtar Alomar, Abdulaziz Almulhim, Sarah Al-Makki, Nazar R. Alrwaili, Shahad Al-Bassam, et al. (+5)
17 [GO] 2022―Mai―20 The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome Alyson Katz, Diana Altshuler, John Papadopoulos, Nancy Amoroso, Ronald Goldenberg, Elizabeth Tarras, et al. (+6)
18 [GO] 2022―Mai―19 Successful Desensitization to Remdesivir Hypersensitivity in a Patient Undergoing Treatment for COVID-19 Da Woon Sim, Eun Myoung, Son Hoyoung
19 [GO] 2022―Mai―02 Two Years of the COVID-19 Pandemic: What Lessons Have We Learned? Shannon Inglet
20 [GO] 2022―Feb―18 Elevated Tacrolimus Levels at Time of Diagnosis of COVID-19 Compared to Baseline Among Hospitalized Organ Transplant Recipients Krista Mecadon, Anna Hardesty, Kendra Vieira, Ralph Rogers, Basma Merhi, Adena J. Osband, et al. (+5)
21 [GO] 2022―Feb―08 COVID-19 Vaccine-Associated Pericarditis Giuseppe Famularo, Maria Cristina Macciomei
22 [GO] 2022―Jan―13 Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge Lindsay A. Courtney, Toby C. Trujillo, Joseph J. Saseen, Garth Wright, Surabhi Palkimas
23 [GO] 2022―Jan―13 Medication Changes and Diagnosis of New Chronic Illnesses in COVID-19 Intensive Care Unit Survivors Rima A. Mohammad, Cynthia T. Nguyen, Patrick G. Costello, Janelle O. Poyant, Siu Yan Amy Yeung, Kaitlin Landolf, et al. (+6)
24 [GO] 2022―Jan―13 Evaluation of Continuous Inhaled Epoprostenol in the Treatment of Acute Respiratory Distress Syndrome, Including Patients With SARS-CoV-2 Infection Hannah L. Niss, Adham Mohamed, Timothy P. Berry, Timothy M. Saettele, Michelle M. Haines, Elizabeth L. Thomas
25 [GO] 2022―Jan―11 Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon Jason Powell, Christopher R. Piszczatoski
26 [GO] 2021―Sep―09 Comment: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019 Ju-Tae Sohn
27 [GO] 2021―Sep―06 Reply: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019 Corey J. Witenko, Audrey J. Littlefield, Sajjad Abedian, Anjile An, Philip S. Barie, Karen Berger
28 [GO] 2021―Sep―02 Hypertriglyceridemia in Critically Ill Patients With SARS-CoV-2 Infection Wasim S. El Nekidy, Abdullah Shatnawei, Manal M. Abdelsalam, Mariam Hassan, Ruba Z. Dajani, Nouran Salem, et al. (+4)
29 [GO] 2021―Jul―31 Comment: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk Brittany D. Bissell, Breanne Mefford, J. Chris Donaldson
30 [GO] 2021―Jul―31 Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk Xian Jie Cindy Chen, Diana Altshuler, Peter Spiegler, Shari B. Brosnahan
31 [GO] 2021―Jul―29 Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure Brittany D. Bissell, Taylor Gabbard, Erica A. Sheridan, Maher A. Baz, George A. Davis, Ayesha Ather
32 [GO] 2021―Jun―28 Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk Shari B. Brosnahan, Xian Jie Cindy Chen, Juri Chung, Diana Altshuler, Shahidul Islam, Sarun V. Thomas, et al. (+6)
33 [GO] 2021―Jun―23 Interventions in an Ambulatory Setting to Prevent Progression to Severe Disease in Patients With COVID-19: A Systematic Review Eamon O Murchu, Susan Spillane, Paula Byrne, Michelle O’Neill, Patricia Harrington, Máirín Ryan
34 [GO] 2021―Jun―02 Sedation Usage in COVID-19 Acute Respiratory Distress Syndrome: A Multicenter Study Natalie Tapaskar, Daniel Colon Hidalgo, Grace Koo, Krupa Shingada, Swathi Rao, Raul Rodriguez, et al. (+9)
35 [GO] 2021―Mai―14 The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019 Corey J. Witenko, Audrey J. Littlefield, Sajjad Abedian, Anjile An, Philip S. Barie, Karen Berger
36 [GO] 2021―Apr―22 Approach to Sedation and Analgesia in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation Diane Dreucean, Jesse E. Harris, Prakruthi Voore, Kevin R. Donahue
37 [GO] 2021―Mrz―04 Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review Helen D. Berlie, Pramodini B. Kale-Pradhan, Tara Orzechowski, Linda A. Jaber
38 [GO] 2020―Dez―11 Hydroxychloroquine-Induced Premature Ventricular Contractions in a Patient With COVID-19 Disease Dhouha Sahnoun, Maha Abid, Neila Fathallah, Foued Belazreg, Chaker Ben Salem
39 [GO] 2020―Mai―27 CORRIGENDUM to Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 (updated to Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19)
40 [GO] 2020―Mai―12 Myth Busters: Dietary Supplements and COVID-19 Kathleen K. Adams, William L. Baker, Diana M. Sobieraj
41 [GO] 2020―Mai―09 Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 Christopher R. Piszczatoski, Jason Powell
 [1] 

41 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.014 sec